On Monday, Canada’s National Advisory Committee on Immunization (NACI) announced it is now recommending AstraZeneca’s COVID-19 vaccine not be administered to people under the age of 55.According to infectious diseases specialist Dr.
Isaac Bogoch, over the last few weeks, there have been rare reports of blood clotting in Europe associated with AstraZeneca.“There were just very rare events.
They were predominantly in women, they were predominantly in people that were under the age of 50,” said Bogoch, adding that based on the accumulation of that data, the NACI looked at the benefits and risks.“They basically drew a line and said… if you’re over 55, this is reasonable, you should be taking this.